Protein-Based Disease and Cancer Screening at the Point of Care

Multiplexed Biomarkers

The current panel of OncoGenesis biomarkers consists of biomarkers that are indicative of all critical molecular changes associated with cervical cancer progression.  Application of these biomarkers in cervical cytology samples will provide a comprehensive assessment of the state of cervical cells from the patients and will be able to identify patients with high-grade lesions who require immediate follow-up or treatment accurately and efficiently.  This test will be particularly useful for triaging HPV positive patients who truly need follow-up and/or treatment from the vast majority of HPV positive individuals who do not have abnormal lesions and who do not need expensive and stressful follow-up procedures.

OncoGenesis’ CerMark™ Biomarkers

matrix iii